FDA product code PRE: Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers

PRE is the FDA product code for rt-qpcr assay for mrna transcript immune biomarkers. It is a Class II device, regulated under 21 CFR 866.3215 and reviewed by the Microbiology panel. FDA has cleared 4 510(k) submissions under PRE, 2 in the last five years, from 2 different applicants. The average 510(k) review took 199 days (median 184); 213 days on average over the last three years.

Definition

A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.

Classification

FieldValue
Device nameRt-Qpcr Assay For Mrna Transcript Immune Biomarkers
Device classClass II
Regulation21 CFR 866.3215
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for PRE

YearClearancesAvg. review days
2017188
20211341
20231155
20251213

Compare with all 510(k) review times · Search every PRE clearance

Top PRE applicants

ApplicantClearancesLatest
Immunexpress, Inc.32023-12-15
Inflammatix, Inc.12025-01-10

Most recent PRE clearances

510(k)ApplicantDeviceDecision dateReview days
K241676Inflammatix, Inc.TriVerity2025-01-10213
K232095Immunexpress, Inc.SeptiCyte RAPID2023-12-15155
K203748Immunexpress, Inc.SeptiCyte RAPID2021-11-29341
K163260Immunexpress, Inc.SeptiCyte LAB2017-02-1788

Recalls for PRE devices

FDA recall records list no recalls for product code PRE.

Frequently asked questions

What is FDA product code PRE?

PRE is the FDA product code for rt-qpcr assay for mrna transcript immune biomarkers. It is a Class II device, regulated under 21 CFR 866.3215 and reviewed by the Microbiology panel.

What device class is PRE?

Class II, regulation 21 CFR 866.3215. Typical premarket route: 510(k).

How long does a 510(k) take for product code PRE?

Across 4 cleared submissions the average was 199 days from receipt to decision (median 184).

Which companies have the most PRE clearances?

Immunexpress, Inc. (3); Inflammatix, Inc. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times